| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |